WO2007100561A3 - Utilisation de dha et d'ara pour la preparation d'une composition destinee a la prevention ou au traitement de l'obesite - Google Patents
Utilisation de dha et d'ara pour la preparation d'une composition destinee a la prevention ou au traitement de l'obesite Download PDFInfo
- Publication number
- WO2007100561A3 WO2007100561A3 PCT/US2007/004421 US2007004421W WO2007100561A3 WO 2007100561 A3 WO2007100561 A3 WO 2007100561A3 US 2007004421 W US2007004421 W US 2007004421W WO 2007100561 A3 WO2007100561 A3 WO 2007100561A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dha
- ara
- preventing
- treating obesity
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Child & Adolescent Psychology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Dairy Products (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002642969A CA2642969A1 (fr) | 2006-02-28 | 2007-02-19 | Utilisation de dha et d'ara pour augmenter la masse musculaire maigre et reduire les tissus adipeux chez les enfants |
BRPI0708378-5A BRPI0708378A2 (pt) | 2006-02-28 | 2007-02-19 | uso de dha e ara na preparação de uma composição para prevenção ou tratamento de obesidade |
EP07751195A EP1988888A2 (fr) | 2006-02-28 | 2007-02-19 | Utilisation de dha et d'ara pour la preparation d'une composition destinee a la prevention ou au traitement de l'obesite |
MX2008010888A MX2008010888A (es) | 2006-02-28 | 2007-02-19 | Metodo para incrementar la masa del musculo magro y disminuir el tejido adiposo. |
NO20082636A NO20082636L (no) | 2006-02-28 | 2008-06-05 | Anvendelse av DHA og ARA for fremstilling av en sammensetning for forebygging eller behandling av fedme |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77734506P | 2006-02-28 | 2006-02-28 | |
US60/777,345 | 2006-02-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007100561A2 WO2007100561A2 (fr) | 2007-09-07 |
WO2007100561A3 true WO2007100561A3 (fr) | 2007-10-18 |
Family
ID=38220602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/004421 WO2007100561A2 (fr) | 2006-02-28 | 2007-02-19 | Utilisation de dha et d'ara pour la preparation d'une composition destinee a la prevention ou au traitement de l'obesite |
Country Status (12)
Country | Link |
---|---|
US (1) | US20070203237A1 (fr) |
EP (1) | EP1988888A2 (fr) |
KR (1) | KR20080103972A (fr) |
CN (1) | CN101389322A (fr) |
BR (1) | BRPI0708378A2 (fr) |
CA (1) | CA2642969A1 (fr) |
IN (1) | IN2008DE06532A (fr) |
MX (1) | MX2008010888A (fr) |
NO (1) | NO20082636L (fr) |
RU (1) | RU2456985C2 (fr) |
TW (1) | TWI388319B (fr) |
WO (1) | WO2007100561A2 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070203235A1 (en) * | 2006-02-28 | 2007-08-30 | Rosales Francisco J | Method for preventing or treating anemia |
WO2007100562A2 (fr) * | 2006-02-28 | 2007-09-07 | Bristol-Myers Squibb Company | Utilisation de dha et d'ara dans la préparation d'une composition permettant de réduire les niveaux de triglycérides |
EP2076256B1 (fr) * | 2006-10-03 | 2016-07-20 | Michael Myers | Compositions de substitution d'un repas et procédé de contrôle de poids |
US8343753B2 (en) | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
US9480670B2 (en) * | 2009-04-01 | 2016-11-01 | Nestec S.A. | Reduction of risk of obesity |
WO2010134800A1 (fr) * | 2009-05-19 | 2010-11-25 | N.V. Nutricia | Agent d'enrichissement du lait destiné à la consommation humaine à forte teneur en protéines et en acides gras polyinsaturés à longue chaîne, destiné à améliorer la répartition du tissu adipeux dans l'organisme |
US8452267B2 (en) | 2009-11-27 | 2013-05-28 | Eazybreak Oy | System and method for granting access to a system |
ES2555032T3 (es) * | 2010-01-19 | 2015-12-28 | Mjn U.S. Holdings Llc | Compensación nutricional para dieta de tipo occidental |
CN101878819B (zh) * | 2010-07-20 | 2012-02-01 | 澳优乳业(中国)有限公司 | 一种含脂联素的婴幼儿配方奶粉及其制备方法 |
US10251928B2 (en) | 2014-11-06 | 2019-04-09 | Mead Johnson Nutrition Company | Nutritional supplements containing a peptide component and uses thereof |
US11109607B2 (en) | 2013-11-18 | 2021-09-07 | Gary Hall | Oil-based compositions for enhancing oral health and general wellness in humans |
US20160317600A1 (en) * | 2013-12-19 | 2016-11-03 | Abbott Laboratories | Nutritional composition comprising hydrolyzed protein |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004012727A1 (fr) * | 2002-08-06 | 2004-02-12 | Abbott Laboratories | Compositions comprenant des acides gras polyinsatures (pufas) utiles pour reguler l'appetit et gerer la masse corporelle |
WO2005063050A1 (fr) * | 2003-12-19 | 2005-07-14 | Abbott Laboratories | Procede pour augmenter la masse maigre et reduire masse adipeuse du nourrisson |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2033193B1 (es) * | 1990-10-30 | 1994-01-16 | Ganadera Union Ind Agro | Mezcla grasa para nutricion infantil y de adultos. |
US20030064950A1 (en) * | 2001-02-23 | 2003-04-03 | Ntambi James M. | Methods for reducing body fat and increasing lean body mass by reducing stearoyl-CoA desaturase 1 activity |
US6753350B1 (en) * | 2003-03-24 | 2004-06-22 | Bristol-Myers Squibb Company | Method to reduce the incidence of intraventricular hemorrhage in preterm infants |
SE0303513D0 (sv) * | 2003-12-19 | 2003-12-19 | Pronova Biocare As | Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof |
-
2007
- 2007-02-19 BR BRPI0708378-5A patent/BRPI0708378A2/pt not_active IP Right Cessation
- 2007-02-19 RU RU2008134874/15A patent/RU2456985C2/ru not_active IP Right Cessation
- 2007-02-19 EP EP07751195A patent/EP1988888A2/fr not_active Withdrawn
- 2007-02-19 KR KR1020087020959A patent/KR20080103972A/ko not_active Application Discontinuation
- 2007-02-19 CA CA002642969A patent/CA2642969A1/fr not_active Abandoned
- 2007-02-19 WO PCT/US2007/004421 patent/WO2007100561A2/fr active Application Filing
- 2007-02-19 MX MX2008010888A patent/MX2008010888A/es unknown
- 2007-02-19 CN CNA2007800069842A patent/CN101389322A/zh active Pending
- 2007-02-27 TW TW096106856A patent/TWI388319B/zh not_active IP Right Cessation
- 2007-02-27 US US11/711,196 patent/US20070203237A1/en not_active Abandoned
-
2008
- 2008-06-05 NO NO20082636A patent/NO20082636L/no not_active Application Discontinuation
- 2008-07-28 IN IN6532DE2008 patent/IN2008DE06532A/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004012727A1 (fr) * | 2002-08-06 | 2004-02-12 | Abbott Laboratories | Compositions comprenant des acides gras polyinsatures (pufas) utiles pour reguler l'appetit et gerer la masse corporelle |
WO2005063050A1 (fr) * | 2003-12-19 | 2005-07-14 | Abbott Laboratories | Procede pour augmenter la masse maigre et reduire masse adipeuse du nourrisson |
Also Published As
Publication number | Publication date |
---|---|
EP1988888A2 (fr) | 2008-11-12 |
BRPI0708378A2 (pt) | 2011-06-07 |
CA2642969A1 (fr) | 2007-09-07 |
KR20080103972A (ko) | 2008-11-28 |
IN2008DE06532A (fr) | 2008-10-24 |
US20070203237A1 (en) | 2007-08-30 |
NO20082636L (no) | 2008-09-29 |
CN101389322A (zh) | 2009-03-18 |
RU2008134874A (ru) | 2010-04-10 |
MX2008010888A (es) | 2008-09-03 |
TWI388319B (zh) | 2013-03-11 |
TW200744573A (en) | 2007-12-16 |
WO2007100561A2 (fr) | 2007-09-07 |
RU2456985C2 (ru) | 2012-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007100561A3 (fr) | Utilisation de dha et d'ara pour la preparation d'une composition destinee a la prevention ou au traitement de l'obesite | |
WO2008089087A3 (fr) | Composition de type comprimé-dans-comprimé | |
ZA200807879B (en) | Use of bifidobacterium longum for the prevention and treatment of inflammation | |
EP2099449A4 (fr) | Composition pharmaceutique pour le traitement et la prévention d'affection impliquant l'impuissance | |
WO2008122049A3 (fr) | Procédés et compositions pour la réduction des effets secondaires des traitements thérapeutiques | |
WO2007103719A3 (fr) | MODULATEURS DE LA 11-β-HYDROXYSTÉROÏDE DÉSHYDROGÉNASE DE TYPE 1, LEURS COMPOSITIONS PHARMACEUTIQUES ET LEURS PROCÉDÉS D'UTILISATION | |
WO2006119958A3 (fr) | Utilisation de la flibanserine dans le traitement de la douleur chronique | |
WO2010127099A3 (fr) | Compositions pharmaceutiques comprenant de l'epa et un agent cardiovasculaire et leurs procédés d'utilisation | |
WO2009079451A3 (fr) | Compositions et procédés pour favoriser la guérison d'une plaie | |
WO2006078463A3 (fr) | Methode de traitement de maladie cardio-vasculaire | |
EP2318033B8 (fr) | Compositions destinées au traitement de la douleur et/ou de l'inflammation | |
WO2008011335A3 (fr) | Composés fixant le métal, compositions fixant le métal, ainsi que leurs applications | |
WO2007138466A3 (fr) | Compositions pharmaceutiques comprenant une combinaison de meloxicam et de tramadol | |
WO2010062581A3 (fr) | Composition botanique pour une réparation cutanée optimisée et utilisations associées | |
WO2007084857A3 (fr) | Procédés et compositions de traitement de troubles prolifératifs cellulaires | |
EP2190408A4 (fr) | Compositions analgésiques et anti-inflammatoires et méthodes permettant de soulager, de prévenir ou de traiter la douleur et l'inflammation | |
HK1129426A1 (zh) | 用於治療肺部病症的酶的合成物 | |
EP2079526A4 (fr) | Compositions et leurs utilisations dans le traitement de lésions | |
EP2068865A4 (fr) | Procédés et compositions pour traitement thérapeutique | |
AU2007243282A8 (en) | Compositions and methods for the treatment of cardiovascular disease | |
WO2007130822A3 (fr) | Modulateurs des récepteurs mglur5 iii | |
WO2007100435A3 (fr) | Utilisation de dha et de ara dans la préparation d'une composition destinée à la prévention ou au traitement de l'anémie | |
EP2217238A4 (fr) | Procédés et compositions pour le traitement de maladies protéinuriques | |
WO2010044585A3 (fr) | Composes de piperidine, composition pharmaceutique les contenant et utilisation associee | |
ZA200900210B (en) | Compositions and methods for preventing or treating cardiovascular diseases in felines with hyperthyroidism |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 12008501372 Country of ref document: PH |
|
WWE | Wipo information: entry into national phase |
Ref document number: 6532/DELNP/2008 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/a/2008/010888 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200780006984.2 Country of ref document: CN Ref document number: 2642969 Country of ref document: CA Ref document number: 2007751195 Country of ref document: EP Ref document number: 1020087020959 Country of ref document: KR |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2008134874 Country of ref document: RU Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: PI0708378 Country of ref document: BR Kind code of ref document: A2 Effective date: 20080828 |